|
1
|
Parkin DM, Ferlay J, Curado MP, Bray F,
Edwards B, Shin HR and Forman D: Fifty years of cancer incidence:
C15 I–IX. Int J Cancer. 127:2918–2927. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lei T, Mao WM, Yang HJ, Chen XZ, Lei TH,
Wang XH, Ying Q, Chen WQ and Zhang SW: Study on cancer incidence
through the cancer registry program in 11 cities and counties,
China. Zhonghua Liu Xing Bing Xue Za Zhi. 30:1165–1170. 2009.(In
Chinese). PubMed/NCBI
|
|
3
|
Chen WQ, Shan BE, Zheng RS, Lin GZ, Chen
JZ, Chen JG and HE YT: Analysis of incidence and mortality of
leukemia in registration areas of China from 2003 to 2007. Tumor.
32:251–255. 2012.
|
|
4
|
Rodriguez-Abreu D, Bordoni A and Zucca E:
Epidemiology of hematological malignancies. Ann Oncol. 18:3–8.
2007. View Article : Google Scholar
|
|
5
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: Global surveillance of cancer survival 1995–2009: Analysis
of individual data for 25,676,887 patients from 279
population-based registries in 67 countries (CONCORD-2). Lancet.
385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Evans AE, Gilbert ES and Zandstra R: The
increasing incidence of central nervous leukemia in children
(Children's Cancer Study Group A). Cancer. 26:404–409. 1970.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niemeyer CM, Hitchcock-Bryan S and Sallan
SE: Comparative analysis of treatment programs for childhood acute
lymphoblastic leukemia. Semin Oncol. 12:122–130. 1985.PubMed/NCBI
|
|
8
|
Walker RW: Neurologic complications of
leukemia. Neurol Clin. 9:989–999. 1991.PubMed/NCBI
|
|
9
|
Feinberg WM and Swenson MR:
Cerebrovascular complications of L-asparaginase therapy. Neurol.
38:127–133. 1988. View Article : Google Scholar
|
|
10
|
Flament-Durand J, Ketelbant-Balasse P,
Maurus R, Regnier R and Spehl M: Intracerebral calcifications
appearing during the course of acute lymphocytic leukemia treated
with methotrexate and X rays. Cancer. 35:319–325. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rubinstein LJ, Herman MM, Long TF and
Wilbur JR: Disseminated necrotizing leukoencephalopathy: A
complication of treated central nervous system leukemia and
lymphoma. Cancer. 35:291–305. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Biti GP, Magrini SM, Villari N, Caramella
D, Guazzelli G, Rosi A and Lippi A: Brain damage after treatment
for acute lymphoblastic leukemia. A report on 34 patients with
special regard to MRI findings. Acta Oncol. 28:253–256. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CY, Zimmerman RA, Faro S, Bilaniuk
LT, Chou TY and Molloy PT: Childhood leukemia: Central nervous
system abnormalities during and after treatment. AJNR Am J
Neuroradiol. 17:295–310. 1996.PubMed/NCBI
|
|
14
|
Faraci M, Lanino E, Dini G, Fondelli MP,
Morreale G, Dallorso S, Manzitti C, Calevo MG, Gaggero R,
Castagnola E and Haupt R: Severe neurologic complications after
hematopoietic stem cell transplantation in children. Neurology.
59:1895–1904. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pui CH and Thiel E: Central nervous system
disease in hematologic malignancies: Historical perspective and
practical applications. Semin Oncol. 36 4 Suppl 2:S2–S16. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Phillips ME, Ryals TJ, Kambhu SA and Yuh
WT: Neoplastic vs inflammatory meningeal enhancement with Gd-DTPA.
J Comput Assist Tomogr. 14:536–541. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ball WS Jr, Prenger EC and Ballard ET:
Neurotoxicity of radio/chemotherapy in children: Pathologic and MR
correlation. AJNR Am J Neuroradiol. 13:761–776. 1992.PubMed/NCBI
|
|
18
|
Asato R, Akiyama Y, Ito M, Kubota M,
Okumura R, Miki Y, Konishi J and Mikawa H: Nuclear magnetic
resonance abnormalities of the cerebral white matter in children
with acute lymphoblastic leukemia and malignant lymphoma during and
after central nervous system prophylactic treatment with
intrathecal methotrexate. Cancer. 70:1997–2004. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsuruda JS, Kortman KE, Bradley WG,
Wheeler DC, Van Dalsem W and Bradley TP: Radiation effects on
cerebral white matter: MR evaluation. AJR Am J Roentgenol.
149:165–171. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Packer RJ, Zimmerman RA and Bilaniuk LT:
Magnetic resonance imaging in the evaluation of treatment-related
central nervous system damage. Cancer. 58:635–640. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ligima K, Hirato M, Miyagishima T,
Horiguchi K, Sugawara K, Hirato J, Yokoo H and Yoshimoto Y:
Microrecording and image-guided stereotactic biopsy of deep-seated
brain tumors. J Neurosurg. 123:978–988. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malikova H, Liscak R, Latnerova I,
Guseynova K, Syrucek M and Pytlik R: Complications of MRI-guided
stereotactic biopsy of brain lymphoma. Neuro Endocrinol Lett.
35:613–618. 2014.PubMed/NCBI
|
|
23
|
Göçmen S, Kutlay M, Erikçi A, Atabey C,
Sayan O and Haholu A: Central nervous system involvement of T-cell
prolymphocytic leukemia diagnosed with stereotactic brain biopsy:
Case report. Turk J Haematol. 31:75–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas X, Boiron JM, Huguet F, Dombret H,
Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P,
et al: Outcome of treatment in adults with acute lymphoblastic
leukemia: Analysis of LALA-94 trial. J Clin Oncol. 22:4075–4086.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kantarjian HM, O'Brien S, Smith TL, Cortes
J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, et al:
Results of treatment with hyper-CVAD, a dose-intensive regimen, in
adult acute lymphocytic leukemia. J Clin Oncol. 18:547–561. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thomas X and Le QH: Central nervous system
involvement in adult acute lymphoblastic leukemia. Hematology.
13:293–302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sung SH and Jang IS: Isolated central
nervous system relapse of acute lymphoblastic leukemia. Brain Tumor
Res Treat. 2:114–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barredo J and Ritchey AK: Controversies in
the management of central nervous system leukemia. Pediatr Hematol
Oncol. 27:329–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Robertson KA: Pediatric bone marrow
transplantation. Curr Opin Pediatr. 5:103–109. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pui CH and Howard SC: Current management
and challenges of malignant disease in the CNS in paediatric
leukemia. Lancet Oncol. 9:257–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Valk PE and Dillon WP: Radiation injury of
the brain. AJNR Am J Neuroradiol. 12:45–62. 1991.PubMed/NCBI
|
|
32
|
Priest JR, Ramsay NK, Steinherz PG,
Tubergen DG, Cairo MS, Sitarz AL, Bishop AJ, White L, Trigg ME,
Levitt CJ, et al: A syndrome of thrombosis and hemorrhage
complicating L-asparaginase therapy for childhood acute
lymphoblastic leukemia. J Pediatr. 100:984–989. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Price RA and Jamieson PA: The central
nervous system in childhood leukemia. II. Subacute
leukoencephalopathy. Cancer. 35:306–318. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Törnebohm E, Lockner D and Paul C: A
retrospective analysis of bleeding complications in 438 patients
with acute leukemia during the years 1972–1991. Eur J Haematol.
50:160–167. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mansour A, Qandeel M, Abdel-Razeq H and
Ali Abu HA: MR imaging features of intracranial primary CNS
lymphoma in immune competent patients. Cancer Imaging.
14:222014.PubMed/NCBI
|
|
36
|
Chan YL, Roebuck DJ, Yuen MP, Yeung KW,
Lau KY, Li CK and Chik KW: Long-term cerebral metabolite changes on
proton magnetic resonance spectroscopy in patients cured of acute
lymphoblastic leukemia with previous intrathecal methotrexate and
cranial irradiation prophylaxis. Int J Radiat Oncol Biol Phys.
50:759–763. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ficek K, Blamek S, Syguła D, Miszczyk L,
Sońta-Jakimczyk D and Tarnawski R: Evaluation of the late effects
of CNS prophylactic treatment in childhood acute lymphoblastic
leukemia (ALL) using magnetic resonance spectroscopy. Acta
Neurochir Suppl. 106:195–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumar R, Nijalingappa S, Grainger J and
Ismayl O: Acute disseminated encephalomyelitis mimicking late CNS
relapse of acute lymphoblastic leukaemia: Case report. J Med Case
Rep. 1:42007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferrés GM, Bidart HT and Zubieta AM:
Important of images and etiological diagnosis of central nervous
system involvement in immunocompromised patients. Rev Chilena
Infectol. 27:541–543. 2010.(In Spanish). PubMed/NCBI
|
|
40
|
Brandt MD, Brandt K, Werner A, Schönfeld
R, Loewenbrück K, Donix M, Schaich M, Bornhäuser M, von Kummer R,
Leplow B and Storch A: Preventive brain radio-chemotherapy alters
plasticity associated metabolite profile in the hippocampus but
seems to not affect spatial memory in young leukemia patients.
Brain Behav. 5:e003682015. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chan YL, Roebuck DJ, Yuen MP, Yeung KW,
Lau KY, Li CK and Chik KW: Long-term cerebral metabolite changes on
proton magnetic resonance spectroscopy in patients cured of acute
lymphoblastic leukemia with previous intrathecal methotrexate and
cranial irradiation prophylaxis. Int J Radiat Oncol Biol Phys.
50:759–763. 2001. View Article : Google Scholar : PubMed/NCBI
|
